News
06-04-2008, 03:54 AM
BN ImmunoTherapeutics, Inc. has initiated Phase I/II clinical studies with its therapeutic vaccine candidate against prostate cancer.
More... (http://www.news-medical.net/?id=38940)
More... (http://www.news-medical.net/?id=38940)